PT Darya-Varia Laboratoria operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Darya-Varia Laboratoria with three other
pharmaceutical manufacturers in Asia:
Wakamoto Pharmaceutical Co., Ltd.
sales of 9.93 billion Japanese Yen [US$97.48 million]
of which 60%
was Medical Pharmaceutical Products),
Lansen Pharmaceutical Holdings Limited
(583.88 million Chinese Renmimbi [US$94.30 million]
of which 61%
was Rheumatic Specialty Prescription Western), and
Guizhou Xinbang Pharmaceutical Company Limited
based in China
(569.36 million Chinese Renmimbi [US$91.95 million]
of which 98%
was Madicinal Manufacturing).
PT Darya-Varia Laboratoria reported sales of 1.10 trillion Indonesian Rupiahs (US$95.19 million)
December of 2013.
a very small
increase of 1.3%
versus 2012, when the company's sales were 1.09 trillion Indonesian Rupiahs.
Sales at PT Darya-Varia Laboratoria have increased during each of the previous five years
(and since 2008, sales have increased a total of 91%).
Sales of Consumer Health saw an increase
that was more than double the company's growth rate: sales were up
9.6% in 2013, from
359.47 billion Indonesian Rupiahs to 393.83 billion Indonesian Rupiahs.
Not all segments of PT Darya-Varia Laboratoria experienced an increase in sales in 2013:
sales of Prescribed Medicines fell 2.9% to 514.67 billion Indonesian Rupiahs.
PT Darya-Varia Laboratoria also experienced decreases in sales in
Toll Manufacturing (down 2.4% to 193.19 billion Indonesian Rupiahs)